Find trials
Search tips

COVID Controls

Overview

About this study

The purpose of this study is to establish whether patients with post-COVID syndrome have different serologic markers than control patients who have had COVID and recovered without progression to post-COVID syndrome.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:  

  • Age ≥ 18 years.
  • Age and gender matched to biorepository cohort.
  • Population specific: 
    • For the never-COVID group – no history of having contracted COVID;
    • For COVID infection without post COVID cohort (+ COVID, - PASC), part of initial acute COVID biorepository;
    • time from onset of symptoms matched to biorepository cohort. 
    • For the + PASC group Included in the PASC biorepository.
  • Matched by age, sex and time of onset of symptoms, as appropriate be able to participate fully in all aspects of the study; and  
  • Have understood and signed study informed consent. 

Exclusion Criteria:   

  • Active persistent COVID infection. 
  • < 40 kg in weight have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence. 
  • Women with a previously confirmed infection with the novel SARS-CoV-2 virus of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation.   

Eligibility last updated 3/2/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ryan Hurt, M.D., Ph.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Jennifer Hanson

(507) 255-6205

Hanson.Jennifer6@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20536236

Mayo Clinic Footer